Compared to the AJCC7 system, the AJCC8 staging system also requires additional information on tumor grade, as well as expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2). This evidence concerns the gene ERBB2 and neoplasm.